Use of nicotine replacement therapy to reduce or delay smoking but not to quit: prevalence and association with subsequent cessation efforts
- PMID: 18048614
- PMCID: PMC2807189
- DOI: 10.1136/tc.2007.021485
Use of nicotine replacement therapy to reduce or delay smoking but not to quit: prevalence and association with subsequent cessation efforts
Abstract
Objective: To assess the prevalence of nicotine replacement therapy (NRT) use for purposes other than quitting smoking and examine the relation of this non-standard NRT use (NSNRT) with subsequent smoking cessation efforts.
Design: A population based cohort study of adult smokers who were interviewed by telephone at baseline (2001-2) and at two year follow-up. The association between NSNRT use to cut down on smoking or to delay smoking before baseline and cessation attempts and smoking outcomes at two year follow-up was assessed using logistic regression to adjust for multiple potential confounding factors.
Setting: Massachusetts, USA.
Subjects: 1712 adult smokers in Massachusetts who were selected using a random digit dial telephone survey.
Main outcome measures: Quit attempt in 12 months before follow-up, NRT use at quit attempt in 12 months before follow-up, smoking cessation by follow-up, or 50% reduction in cigarettes smoked per day between baseline and follow-up.
Results: 18.7% of respondents reported ever having used NSNRT. In a multiple logistic regression analysis, there was no statistically significant association between past NSNRT use and quit attempts (OR(cut down) = 0.89, 95% CI 0.59 to 1.33; OR(delay) = 1.29, 95% CI 0.73 to 2.29), smoking cessation (OR(cut down) = 0.74, 95% CI 0.43 to 1.24; OR(delay) = 1.22, 95% CI 0.60 to 2.50) or 50% reduction in cigarettes smoked per day (OR(cut down) = 0.93, 95% CI 0.62 to 1.38; OR(delay) = 0.80, 95% CI 0.43 to 1.49) at follow-up. Past use of NRT to cut down on cigarettes was associated with use of NRT at a follow-up quit attempt (OR(cut down) = 2.28, 95% CI 1.50 to 3.47) but past use of NRT to delay smoking was not (OR(delay) = 1.25, 95% CI 0.67 to 2.34).
Conclusions: Use of NRT for reasons other than quitting smoking may be more common than was previously estimated. This population based survey finds no strong evidence that NRT use for purposes other than quitting smoking is either harmful or helpful.
Conflict of interest statement
Competing interests: NAR has received research grants from Pfizer, Sanofi‐Aventis, Nabi Biopharmaceuticals, and Glaxo Smith Kline. She has consulted for Pfizer and Sanofi‐Aventis. The other authors report no competing interests.
Similar articles
-
Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study.Thorax. 2007 Nov;62(11):998-1002. doi: 10.1136/thx.2007.078758. Epub 2007 Jun 15. Thorax. 2007. PMID: 17573444 Free PMC article.
-
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.Cochrane Database Syst Rev. 2019 Apr 18;4(4):CD013308. doi: 10.1002/14651858.CD013308. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2023 Jun 19;6:CD013308. doi: 10.1002/14651858.CD013308.pub2. PMID: 30997928 Free PMC article. Updated.
-
Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey.Addiction. 2008 Oct;103(10):1696-703. doi: 10.1111/j.1360-0443.2008.02320.x. Addiction. 2008. PMID: 18821877 Free PMC article.
-
Smoking reduction interventions for smoking cessation.Cochrane Database Syst Rev. 2019 Sep 30;9(9):CD013183. doi: 10.1002/14651858.CD013183.pub2. Cochrane Database Syst Rev. 2019. PMID: 31565800 Free PMC article.
-
Is dual use of nicotine products and cigarettes associated with smoking reduction and cessation behaviours? A prospective study in England.BMJ Open. 2020 Mar 15;10(3):e036055. doi: 10.1136/bmjopen-2019-036055. BMJ Open. 2020. PMID: 32179563 Free PMC article.
Cited by
-
Comparative effectiveness of motivation phase intervention components for use with smokers unwilling to quit: a factorial screening experiment.Addiction. 2016 Jan;111(1):117-28. doi: 10.1111/add.13161. Epub 2015 Nov 19. Addiction. 2016. PMID: 26582140 Free PMC article. Clinical Trial.
-
US smokers' reactions to a brief trial of oral nicotine products.Harm Reduct J. 2011 Jan 10;8:1. doi: 10.1186/1477-7517-8-1. Harm Reduct J. 2011. PMID: 21219609 Free PMC article.
-
Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?Psychol Addict Behav. 2008 Dec;22(4):472-85. doi: 10.1037/0893-164X.22.4.472. Psychol Addict Behav. 2008. PMID: 19071972 Free PMC article. Review.
-
Integrating tobacco treatment into cancer care: Study protocol for a randomized controlled comparative effectiveness trial.Contemp Clin Trials. 2016 Sep;50:54-65. doi: 10.1016/j.cct.2016.07.016. Epub 2016 Jul 19. Contemp Clin Trials. 2016. PMID: 27444428 Free PMC article. Clinical Trial.
-
How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor.Addiction. 2018 Mar;113(3):391-404. doi: 10.1111/add.14020. Epub 2017 Oct 3. Addiction. 2018. PMID: 28975720 Free PMC article.
References
-
- Pierce J P, Gilpin E A. Impact of over‐the‐counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 20022881260–1264. - PubMed
-
- Fiore M C, Bailey W C, Cohen S J.et alTreating tobacco use and dependence. A clinical practice guideline. Rockville, MD: United States Department of Health and Human Services, Public Health Service, 2000
-
- Report of the Committee on Safety of Medicines Working Group on Nicotine Replacement Therapy: Medicines and Healthcare products Regulatory Agency: Committee on Safety of Medicines 2005
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous